Cargando…
How the COVID-19 pandemic changed treatment of severe aortic stenosis: a single cardiac center experience
BACKGROUND: Currently, two effective therapeutic options for severe aortic stenosis (AS) are available, one catheter-based [transcatheter aortic valve implantation (TAVI)], the other open surgical approach [surgical aortic valve replacement (SAVR)]. The COVID-19 pandemic has limited the availability...
Autores principales: | Perek, Bartlomiej, Olasinska-Wisniewska, Anna, Misterski, Marcin, Puslecki, Mateusz, Grygier, Marek, Buczkowski, Piotr, Lesiak, Maciej, Stankowski, Tomasz, Szarpak, Lukasz, Ruetzler, Kurt, Turan, Oguz, Jemielity, Marek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947507/ https://www.ncbi.nlm.nih.gov/pubmed/33717563 http://dx.doi.org/10.21037/jtd-20-3025 |
Ejemplares similares
-
Sutureless aortic bioprosthesis: Competitor or alternative for transcatheter aortic valve implantation? Single center experience with Perceval valves
por: Olasińska-Wiśniewska, Anna, et al.
Publicado: (2022) -
Late consequences of masked bioprosthetic valve endocarditis: diagnostic and treatment options
por: Katarzyńska, Dominika, et al.
Publicado: (2023) -
Transapical aortic valve implantation using a Symetis Acurate self-expandable bioprosthesis: initial outcomes of 10 patients
por: Misterski, Marcin, et al.
Publicado: (2017) -
Association between time-related changes in routine blood morphological parameters and renal function after transcatheter aortic valve implantation – a preliminary study
por: Stelmark, Konrad, et al.
Publicado: (2021) -
A comparative study of minimally invasive aortic valve replacement with sutureless biological versus mechanical prostheses
por: Bociański, Michał, et al.
Publicado: (2023)